Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly Lymphoma Patients”

210 trials

Showing 20 of 210 results

Large-scale testing (Phase 3)Study completedNCT00053768
What this trial is testing

Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 392
Testing effectiveness (Phase 2)Active Not RecruitingNCT07538180
What this trial is testing

Serplulimab, Chidamide, and Rituximab Followed by Sequential R-CHOP for Newly Diagnosed Elderly MYC/BCL2 Double-Expressor DLBCL

Who this might be right for
Newly Diagnosed MYC/BCL2 Double-expressor DLBCL
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT00169143
What this trial is testing

Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma

Who this might be right for
Untreated CD20-positive Large B-cell Lymphoma
Lymphoma Study Association 60
Early research (Phase 1)Ended earlyNCT01551043
What this trial is testing

Allo CART-19 Protocol

Who this might be right for
Acute Lymphocytic Leukemia
University of Pennsylvania 2
Testing effectiveness (Phase 2)Study completedNCT03580408
What this trial is testing

Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaCoexisting Medical Conditions
The Lymphoma Academic Research Organisation 64
Not applicableStudy completedNCT05101759
What this trial is testing

Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy

Who this might be right for
Neoplasm, Plasma CellLymphoma
University Hospital, Toulouse 100
Large-scale testing (Phase 3)UnknownNCT02313389
What this trial is testing

Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Assistance Publique - Hôpitaux de Paris 428
Large-scale testing (Phase 3)Ended earlyNCT00060385
What this trial is testing

Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 3
Testing effectiveness (Phase 2)Study completedNCT00003278
What this trial is testing

Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 28
Testing effectiveness (Phase 2)Study completedNCT03567876
What this trial is testing

Rituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCL

Who this might be right for
Lymphoma, Mantle-Cell
Fondazione Italiana Linfomi - ETS 141
Testing effectiveness (Phase 2)Active Not RecruitingNCT04446962
What this trial is testing

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

Who this might be right for
Lymphoma, Large B-Cell, DiffuseCentral Nervous System Neoplasms, Primary
Institut Curie 118
Testing effectiveness (Phase 2)Ended earlyNCT00003113
What this trial is testing

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT01285765
What this trial is testing

Evaluate a Treatment Adapted to the PET Response Compared to a Standard Treatment, for Low Risk DLBCL CD 20+ Patients

Who this might be right for
DLBCL
The Lymphoma Academic Research Organisation 650
Testing effectiveness (Phase 2)Active Not RecruitingNCT05004064
What this trial is testing

Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
University College, London 48
Not applicableUnknownNCT02156726
What this trial is testing

Observational Study of Low Dose FCR in Elderly/Comorbid CLL/SLL: The Q-lite Project

Who this might be right for
Chronic Lymphocytic Leukemia
Czech CLL Study Group 200
Not applicableStudy completedNCT03530969
What this trial is testing

Geriatric Communication Skills Training Program for Oncology Clinicians

Who this might be right for
GI CancerLymphomaGU Cancer+1 more
Memorial Sloan Kettering Cancer Center 88
Testing effectiveness (Phase 2)UnknownNCT05428670
What this trial is testing

The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma.

Who this might be right for
Diffuse Large B Cell Lymphoma
First Affiliated Hospital of Wenzhou Medical University 150
Not applicableUnknownNCT05429918
What this trial is testing

Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years

Who this might be right for
Mantle Cell Lymphoma
Peking University Third Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07012980
What this trial is testing

Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
Shanghai Zhongshan Hospital 38
Testing effectiveness (Phase 2)Study completedNCT01087424
What this trial is testing

Mini-CHOP and Rituximab in Patients Aged Over 80 Years

Who this might be right for
Diffuse Large B-Cell Lymphoma
Lymphoma Study Association 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation